| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028140597 |
| P356 | DOI | 10.1186/S13058-014-0477-8 |
| P932 | PMC publication ID | 4318222 |
| P698 | PubMed publication ID | 25499601 |
| P5875 | ResearchGate publication ID | 269718286 |
| P50 | author | Giske Ursin | Q46387795 |
| Leslie Bernstein | Q60607806 | ||
| David Van Den Berg | Q60686183 | ||
| Anna H Wu | Q89864403 | ||
| P2093 | author name string | Juan Pablo Lewinger | |
| Eunjung Lee | |||
| Fredrick R Schumacher | |||
| Yu-Chen Su | |||
| Jianning Luo | |||
| P2860 | cites work | Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium | Q24614574 |
| A map of human genome variation from population-scale sequencing | Q24617794 | ||
| Genotype imputation with thousands of genomes | Q24633967 | ||
| The protective role of pregnancy in breast cancer | Q24810274 | ||
| Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study | Q24810286 | ||
| Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers | Q26865148 | ||
| Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial | Q44978588 | ||
| Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population | Q46061086 | ||
| Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk | Q46145812 | ||
| Organic anion transporter 1B1: an important factor in hepatic thyroid hormone and estrogen transport and metabolism | Q46578756 | ||
| Age-specific trends in mammographic density: the Minnesota Breast Cancer Family Study | Q46667230 | ||
| Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial | Q46713495 | ||
| Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density | Q46990583 | ||
| Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). | Q48551885 | ||
| Hormone replacement therapy regimens and breast cancer risk(1). | Q52954054 | ||
| Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control Study | Q59288218 | ||
| The International HapMap Project | Q27860695 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer | Q28142158 | ||
| Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans | Q28209488 | ||
| Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis | Q28215491 | ||
| Fast and accurate genotype imputation in genome-wide association studies through pre-phasing | Q29614942 | ||
| Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease | Q30705774 | ||
| Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study | Q30815307 | ||
| Snagger: a user-friendly program for incorporating additional information for tagSNP selection | Q33326038 | ||
| Short-term hormone therapy suspension and mammography recall: a randomized trial | Q33577256 | ||
| Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort | Q33892873 | ||
| National use of postmenopausal hormone therapy: annual trends and response to recent evidence | Q34288307 | ||
| Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel | Q34461378 | ||
| Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis | Q34572280 | ||
| Impact of OATP transporters on pharmacokinetics | Q34612244 | ||
| Common variants in ZNF365 are associated with both mammographic density and breast cancer risk | Q34792833 | ||
| Breast cancer after use of estrogen plus progestin in postmenopausal women | Q34938322 | ||
| Predictors of breast density change after hormone therapy cessation: results from a randomized trial. | Q35291645 | ||
| The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort | Q35558999 | ||
| Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study | Q35836312 | ||
| Mammographic density, parity and age at first birth, and risk of breast cancer: an analysis of four case-control studies | Q35911522 | ||
| Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis | Q36507079 | ||
| So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests | Q36512128 | ||
| Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk | Q36600605 | ||
| Increases in serum estrone sulfate level are associated with increased mammographic density during menopausal hormone therapy | Q37349755 | ||
| Mammographic density: a heritable risk factor for breast cancer | Q37358052 | ||
| Pathway analysis by adaptive combination of P-values | Q37464310 | ||
| Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment | Q37691149 | ||
| High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). | Q40631500 | ||
| Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators | Q41611541 | ||
| Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin | Q41719517 | ||
| Steroid and gonadotropin levels in women during the peri-menopausal years | Q42207789 | ||
| Determinants of percentage and area measures of mammographic density | Q43243211 | ||
| Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C. | Q43781832 | ||
| Postmenopausal hormone therapy and change in mammographic density | Q44267695 | ||
| Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden. | Q44356027 | ||
| Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk | Q44507925 | ||
| A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density | Q72243376 | ||
| Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy | Q73437260 | ||
| ACOG Practice Bulletin No. 141: management of menopausal symptoms | Q87164923 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P921 | main subject | California | Q99 |
| P304 | page(s) | 477 | |
| P577 | publication date | 2014-12-11 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study | |
| P478 | volume | 16 |
| Q36253742 | A Model of Compound Heterozygous, Loss-of-Function Alleles Is Broadly Consistent with Observations from Complex-Disease GWAS Datasets |
| Q45067334 | A Randomized Controlled Trial of Green Tea Extract Supplementation and Mammographic Density in Postmenopausal Women at Increased Risk of Breast Cancer |
| Q31044244 | Efficient Software for Multi-marker, Region-Based Analysis of GWAS Data |
| Q58605247 | Growth factor genes and change in mammographic density after stopping combined hormone therapy in the California Teachers Study |
Search more.